The P&G-Merck KGaA Consumer Health Business Merger
| Case Code: BSTR618 Case Length: 14 Pages Period: - Pub Date: 2020 Teaching Note: Available |
Price: Rs.400 Organization: Procter & Gamble Company Industry: - Countries: United States Themes: M&A, Divestment |
Abstract Case Intro 1 Case Intro 2 Excerpts
Introduction
On April 18, 2018, US multinational FMCG major Procter & Gamble Company (P&G) acquired a 100% stake in the Consumer Health Business (CHB) of Merck KGaA (Merck), a global pharmaceutical company headquartered in Germany. David Taylor, Chairman of the Board, President and Chief Executive Officer of P&G, said, “We like the steady, broad-based growth of the OTC Health Care market and are pleased to add the Consumer Health portfolio and people of Merck KGaA, Darmstadt, Germany, to the P&G family.” Stefan Oschmann, Chairman of the Executive Board and CEO of Merck, said, “Consumer Health is a strong business that deserves the best possible opportunities for its future development. With P&G we have found a strong, highly recognized player who has the necessary scale to successfully drive the business going forward.”..
Buy this case study (Please select any one of the payment options)
| Price: Rs.400 |
Price: Rs.400 | PayPal (9 USD) |
